These reports suggest the use of XOR inhibitors in the case of asymptomatic hyperuricemia associated with chronic kidney disease to delay the onset of renal failure or to reduce the risk of adverse cardiovascular events in patients with gout. The gene discussed is XDH; the disease is gout.